About this trial
Phase 1: In 51 patients undergoing shoulder arthroplasties, total serum testosterone, free testosterone and sex hormone binding globulin levels obtained in the clinic before surgery were correlated with the levels of Cutibacterium on the skin in clinic, in the operating room prior to surgery, and in the skin incision.
Phase 2: The investigators wish to determine if preoperative serum testosterone levels are associated with risk for shoulder PJI (periprosthetic joint infection) in patients undergoing primary shoulder arthroplasty. Also to determine if preoperative serum testosterone levels are predictive of bacterial load of deep tissue cultures taken at the time of revision shoulder arthroplasty in patients undergoing primary shoulder arthroplasty.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients having elective shoulder arthroplasty
Disqualifiers
history of shoulder septic arthritis
antibiotic use within 3 months prior to surgery
recent treatment for acne
Lacked fluency in English
Trial population
Phase 1 and 2: Subjects will be adult patients who present to the UWMC Bone \& Joint Center for pre-operative appointments for elective shoulder arthroplasty.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Serum testosterone
Free testosterone
sex hormone binding globulin
Cutibacterium specimen value
Sponsors and contacts
Click on the lead sponsor to view all of their trials.